Form 4 for ASMB ASSEMBLY BIOSCIENCES, INC.
Accepted 2023-06-23 00:00:00 ET · period of report 2023-06-22 · accession 0001209191-23-039531 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-23 | 2023-06-22 | ASMB | Okazaki Jason A | CEO, Pres, Dir | A - Grant | $0.00 | +50.0K | 176.6K | +39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-22 | A | A | 50,000 | $0.00 | 176,613 | D | — | — | (F1) Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On June 22, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024. |